Promab Biotechnologies Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Promab Biotechnologies

Access the complete profile.

Promab Biotechnologies Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	2600 Hilltop Dr Bldgb320 Richmond, CA 94806

Note: Revenues for privately held companies are statistical evaluations.


Promab Biotechnologies's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Promab Biotechnologies's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Promab Biotechnologies is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Promab Biotechnologies Annual Revenue and Growth Rate

Promab Biotechnologies	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Promab Biotechnologies's revenues are gauged from an analysis of company filings.

Promab Biotechnologies's Income Statement (based on Industry Averages)

Promab Biotechnologies P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Promab Biotechnologies is developing and marketing. Promab Biotechnologies doesn't have any recent trademark applications, indicating Promab Biotechnologies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PROMAB Reagents for research purposes, namely, stem cells, monoclonal antibodies, and recombinant proteins	11/18/2013
PROMAB BIOTECHNOLOGIES, INC. Reagents for research purposes, namely, stem cells, monoclonal antibodies, and recombinant proteins	11/18/2013

See all trademarks and details in the Full Report.

Market Share of Promab Biotechnologies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Promab Biotechnologies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Promab Biotechnologies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SANGAMO THERAPEUTICS	Richmond, CA	100
X-THERMA	San Pablo, CA	7
PROMAB BIOTECHNOLOGIES	Richmond, CA	6
MIRRORCLE TECHNOLOGIES	Richmond, CA	3
GAMMA REALITY	Richmond, CA	3
STAIDSON BIOPHARMA	San Pablo, CA	2

Future Competition: Promab Biotechnologies's Fastest Growing Competitors

These companies are in the same general field as Promab Biotechnologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)